|
Market Closed -
Euronext Paris
11:55:00 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 0.8560 EUR | -0.47% |
|
+6.47% | +23.34% |
| 07-22 | Valbiotis Publishes Results of Reverse-It Clinical Study Evaluating Totum 63 in Nature Communications | CI |
| 06-29 | Valbiotis Raises EUR10 Million for Commercial Development, Working Capital | MT |
Chart: Technical Analysis
Stock exchange
Euronext Paris
ALVAL 0.8560 €
-0.47%
79.63K
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Euronext Paris
| ALVAL | 0.8560EUR | -0.47% | 79.63K € | |
Börse Stuttgart
| 8JD | 0.8180EUR | -3.20% | 7.36K € | |
Deutsche Boerse AG
| 8JD | 0.8330EUR | +0.97% | 0 € | |
Boerse Muenchen
| 8JD | 0.8580EUR | -1.94% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Neutral |
| Resistance | 0.869 | 0.92 | 1.154 |
| Spread/Res. | -1.50% | -6.96% | -25.82% |
| Spread/Supp. | +6.34% | +14.90% | +55.64% |
| Support | 0.805 | 0.745 | 0.55 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALVAL Stock
- Charts Valbiotis
Select your edition
All financial news and data tailored to specific country editions

















